Impella in cardiogenic shock following acute myocardial infarction: a systematic review and meta-analysis

Wiener klinische Wochenschrift
Kris G VargasKurt Huber

Abstract

Cardiogenic shock (CS) conveys a high mortality risk. A cardiac assist device may serve as bridge to patient recovery. We aimed to provide a pooled estimate on mortality and complications from studies evaluating the use of the left ventricular assist device Impella in CS following acute myocardial infarction. In addition, we evaluated whether mortality risk differed with device placement before or after percutaneous coronary intervention (PCI). We searched Medline, Embase and Web of Science from 2005 until July 2019 for observational studies or clinical trials on this specific patient group. Studies were required to report on 30-day all-cause mortality and device-related complications. We calculated pooled proportions with 95% confidence intervals (CI) using random effects models and the inverse variance method. Overall, 671 patients from 11 studies (2 randomized and 9 observational) were included. Pooled proportions showed a 30-day mortality of 54.6% (95% CI 47.3-61.8; P = 0.22; I2 = 65.8%). Among complications, major bleeding was found in 19.9% (95% CI 14.2-27.3; P < 0.05; I2 = 69.1%), hemolysis in 10.5% (95% CI 7.2-15.0; P < 0.05; I2 = 52.1%), limb ischemia in 5.0% (95% CI 2.6-9.5; P < 0.05; I2 = 48.3%) and stroke in 3.8% of...Continue Reading

References

Jul 23, 2009·BMJ : British Medical Journal·David MoherUNKNOWN PRISMA Group
Oct 20, 2011·BMJ : British Medical Journal·Julian P T HigginsUNKNOWN Cochrane Statistical Methods Group
Oct 17, 2013·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Brijeshwar MainiLarisa Buyantseva
Apr 17, 2014·Expert Review of Pharmacoeconomics & Outcomes Research·Brijeshwar MainiDavid Gregory
Mar 4, 2015·European Heart Journal·Holger ThieleSuzanne de Waha
Sep 14, 2015·International Journal of Cardiology·Francesco BurzottaJosé P S Henriques
Nov 5, 2016·Journal of the American College of Cardiology·Dagmar M OuweneelJosé P S Henriques
Nov 5, 2016·Journal of the American College of Cardiology·Dagmar M OuweneelJosé P S Henriques
Nov 5, 2016·Journal of the American College of Cardiology·Uwe Zeymer, Holger Thiele
Dec 15, 2017·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Marc MouradPascal H Colson
Aug 25, 2018·Innovations : Technology and Techniques in Cardiothoracic and Vascular Surgery·George BatsidesMark B Anderson
Aug 31, 2018·European Heart Journal·Franz-Josef NeumannUNKNOWN ESC Scientific Document Group
Nov 8, 2018·European Heart Journal. Acute Cardiovascular Care·Dagmar M OuweneelJosé Ps Henriques
Nov 21, 2018·European Heart Journal. Acute Cardiovascular Care·Tobias LoehnKarim Ibrahim
Dec 28, 2018·Circulation·Benedikt SchrageDirk Westermann
Mar 23, 2019·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Bernhard WernlyAlexander Lauten
Jun 9, 2019·American Heart Journal·Nanna Junker UdesenUNKNOWN DanGer Shock investigators

❮ Previous
Next ❯

Citations

Mar 12, 2021·Current Neurology and Neuroscience Reports·Aaron ShoskesSung-Min Cho

❮ Previous
Next ❯

Related Concepts

Related Feeds

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.

Cardiogenic Shock

Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.